We hypothesize that the overly activated IFN signaling, evidenced by increased hepatic ISGs expression (RSAD2 and NRIR), which is associated with unfavorable IFNL genotype, may be one of the factors contributing to elevated iron indices observed in CHC patients. The gene discussed is RSAD2; the disease is cryohydrocytosis.